You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fingolimod

Showing 1 - 25 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intracerebral Hemorrhage Trial (Fingolimod)

Not yet recruiting
  • Intracerebral Hemorrhage
  • Fingolimod
  • (no location specified)
Oct 17, 2023

Chemo-Induced Peripheral Neuropathy, Numbness, Pain Trial in Rochester, Columbus (Fingolimod, Fingolimod Hydrochloride,

Active, not recruiting
  • Chemotherapy-Induced Peripheral Neuropathy
  • +3 more
  • Fingolimod
  • +2 more
  • Rochester, Minnesota
  • +1 more
Jan 17, 2023

Breast Carcinoma Trial in Rochester, Columbus, Richmond (Fingolimod, Fingolimod Hydrochloride, Questionnaire Administration)

Active, not recruiting
  • Breast Carcinoma
  • Fingolimod
  • +2 more
  • Rochester, Minnesota
  • +2 more
Jul 6, 2022

Interstitial Fibrosis, Kidney Transplant; Complications, Kidney Transplant Rejection Trial in Houston (Fingolimod, Placebo)

Enrolling by invitation
  • Interstitial Fibrosis
  • +6 more
  • Fingolimod
  • Placebo
  • Houston, Texas
    Houston Methodist Research Institute
Jan 23, 2023

Stroke Inflammation Trial in Fuzhou (Fingolimod)

Recruiting
  • Stroke Inflammation
  • Fingolimod
  • Fuzhou, China
    The First Affiliated Hospital of Fujian Medical University
Apr 12, 2022

Generic Fingolimod in Relapsing-Remitting Multiple Sclerosis in

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
  • Fingolimod
  • Alexandria, Egypt
  • +1 more
Jun 14, 2022

Diabetes, Type 2 Trial in Shenyang (Fingolimod, guideline-based treatment for DM)

Recruiting
  • Diabetes Mellitus, Type 2
  • Fingolimod
  • guideline-based treatment for DM
  • Shenyang, China
    Department of Neurology, General Hospital of Northern Theater Co
Mar 31, 2022

Impact of Fingolimod Adherence on Outcomes

Completed
  • Multiple Sclerosis
  • Fingolimod
  • East Hanover, New Jersey
    Novartis Investigational Site
Dec 15, 2021

Stroke, Inflammation Trial in Hangzhou (Fingolimod)

Withdrawn
  • Stroke
  • Inflammation
  • Fingolimod
  • Hangzhou, Zhejiang, China
    The second affiliated hospital of Zhejiang University
Jul 15, 2021

Relationship Between Oral DMT Burden and Adherence in MS

Enrolling by invitation
  • Multiple Sclerosis
  • Adherence, Medication
  • Melbourne, Victoria, Australia
    Monash University
Aug 28, 2022

Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate

Recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +8 more
  • Eden Prairie, Minnesota
    OptumInsight
Jan 9, 2023

Multiple Sclerosis (MS) Trial in Worldwide (Fingolimod, Ofatumumab, Siponimod)

Recruiting
  • Multiple Sclerosis (MS)
  • Fingolimod
  • +5 more
  • Little Rock, Arkansas
  • +55 more
Jan 13, 2023

Stroke, Inflammation Trial in Hangzhou (Fingolimod, Placebo)

Unknown status
  • Stroke
  • Inflammation
  • Fingolimod
  • Placebo
  • Hangzhou, Zhejiang, China
    The second affiliated hospital of Zhejiang University
Jul 17, 2021

Stroke Trial (Fingolimod, )

Not yet recruiting
  • Stroke
  • Fingolimod
  • placebo
  • (no location specified)
Jan 17, 2021

Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Fingolimod, Placebo capsule)

Recruiting
Has Results
  • Multiple Sclerosis
  • Interferon beta-1a
  • +3 more
  • Birmingham, Alabama
  • +106 more
Jan 13, 2023

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Ocrelizumab Placebo, Fingolimod)

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
  • La Jolla, California
  • +66 more
Jan 27, 2023

Multiple Sclerosis Trial in Belgium, Germany, Italy (Fingolimod)

Completed
Has Results
  • Multiple Sclerosis
  • Fingolimod
  • Gent, Belgium
  • +3 more
Jan 21, 2021

Relapsing Multiple Sclerosis Trial in United States (Fingolimod)

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • Fingolimod
  • Birmingham, Alabama
  • +65 more
Oct 6, 2021

Relapsing Remitting Multiple Sclerosis Trial in Milan (Fingolimod, Dimethyl Fumarate)

Terminated
  • Relapsing Remitting Multiple Sclerosis
  • Fingolimod
  • Dimethyl Fumarate
  • Milan, Italy
    Fondazione IRCCS Istituto Neurologico C. Besta, Neuroimmunology
Oct 29, 2019

Multiple Sclerosis Treated Fingolimod or Other Approved

Completed
  • Multiple Sclerosis
  • other disease-modifying therapy
  • Fingolimod
  • Birmingham, Alabama
  • +237 more
Dec 28, 2021

Relapsing Remitting Multiple Sclerosis Trial in Puerto Rico, United States (Fingolimod, Disease Modifying therapy)

Completed
Has Results
  • Relapsing Remitting Multiple Sclerosis
  • Fingolimod
  • Disease Modifying therapy
  • Cullman, Alabama
  • +122 more
Dec 9, 2020

Relapsing Remitting Multiple Sclerosis RRMS Trial in Germany, Switzerland (Fingolimod)

Completed
Has Results
  • Relapsing Remitting Multiple Sclerosis RRMS
  • Fingolimod
  • Bochum, Germany
  • +9 more
Feb 14, 2020

Relapsing Forms of Multiple Sclerosis Trial in Worldwide (Fingolimod)

Completed
Has Results
  • Relapsing Forms of Multiple Sclerosis
  • Fingolimod
  • Cullman, Alabama
  • +457 more
Mar 26, 2021

Multiple Sclerosis Trial (Fingolimod, Fish Oil, Placebo (for Fish Oil))

Completed
Has Results
  • Multiple Sclerosis
  • Fingolimod
  • +2 more
  • (no location specified)
Apr 23, 2019

Schizophrenia Trial in Indianapolis (Fingolimod, )

Completed
Has Results
  • Schizophrenia
  • Fingolimod
  • placebo
  • Indianapolis, Indiana
  • +2 more
Mar 25, 2019